Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Epstein-Barr Virus Vaccines
Jennifer M. Geris
, Henry H. Balfour
Laboratory Medicine and Pathology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Epstein-Barr Virus Vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Epstein-Barr Virus
100%
Virus Vaccine
100%
Multiple Sclerosis
20%
Autoimmune Disease
20%
Infectious Mononucleosis
20%
Human Pathogens
20%
Cancer Disease
20%
Immunology and Microbiology
Epstein Barr Virus Vaccine
100%
Epstein Barr Virus
66%
Mononucleosis
33%
Human Pathogen
33%
Multiple Sclerosis
33%
Autoimmune Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein Barr Virus Vaccine
100%
Epstein-Barr Virus
66%
Mononucleosis
33%
Multiple Sclerosis
33%
Autoimmune Disease
33%
Diseases
33%